The Synthesis and Biological Evaluation of a Novel Pleuromutilin Derivative Containing a 4-Fluorophenyl Group Targeting MRSA
Molecules · 2025
DOI: 10.3390/molecules30112366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Yongfei Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Clinical Pharmacology, College of Veterinary Medicine, Inner Mongolia Agricultural University, No. 29, Erdosdong Road, Hohho…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Diterpenes, Polycyclic Compounds, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inner Mongolia Autonomous Region, the Inner Mongolia Natural Science Foundation project, Inner Mongolia Agricultural University young teachers research ability promotion project.
Abstract (Originalsprache)
The pleuromutilin derivative, the compound PL-W, was synthesized by introducing a 4-fluorophenyl group at the C21 position and selected for comprehensive antibacterial evaluation. PL-W demonstrated notable antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA), with a minimum inhibitory concentration (MIC) of 0.03125 µg/mL, which is significantly lower than that of tiamulin (0.5 µg/mL). Crystal violet (CV) staining revealed that it inhibited MRSA biofilm formation and electron microscopy revealed that it disrupted bacterial cell division and, possibly, the synthesis of essential cell wall proteins. In both in vivo models, PL-W exhibited excellent performance. In the Galleria mellonella infection model, treatment with different concentrations of PL-W increased the survival rate from 20% to 90% and significantly reduced the bacterial load. In the mouse model of MRSA pneumonia, a 10 mg/kg dose of PL-W increased the survival rate to 70%, decreased the bacterial load in the lungs, and alleviated inflammatory damage. Molecular docking studies indicated that PL-W had a similar docking pose and comparable binding affinity to that of lefamulin, with hydrogen bond interactions that are crucial for binding to the peptidyl transferase center (PTC). Moreover, it demonstrated no significant reduction in cell viability in HepG2 and HEK293 cells, even at high concentrations (≤50 µg/mL). Overall, PL-W shows significant potential as a novel anti-MRSA agent owing to its potent in vitro and in vivo activities and low cytotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Veterinary Clinical Pharmacology, College of Veterinary Medicine, Inner Mongolia Agricultural University, No. 29, Erdosdong Road, Hohhot 010011, China.
- Experimental Animal Center, Inner Mongolia Medical University, Hohhot 010110, China.
- Shandong Provincial Animal and Poultry Green Health Products Creation Engineering Laboratory, Institute of Poultry Science, Shandong Academy of Agricultural Science, Jinan 250100, China.
ORCID-Profile: Yi Zhao
Förderung
- Inner Mongolia Autonomous Region
- the Inner Mongolia Natural Science Foundation project
- Inner Mongolia Agricultural University young teachers research ability promotion project
- Inner Mongolia Autonomous Region Department of Education first-class scientific research pro-ject
- Science and Technology Program of the Inner Mongolia Autonomous Region
- the Inner Mongolia Medical University Youth Project
- Inner Mongolia Autonomous Region “University Youth Science and Technology talents”
- Inner Mongolia Natural Science Foundation project
Zitieren
APA
Wang, Y., Zhao, Y., Wang, H., Liu, B., Zhang, S., Liu, Y., Li, R., Zhang, T., Hasi, S., & Mao, W. (2025). The Synthesis and Biological Evaluation of a Novel Pleuromutilin Derivative Containing a 4-Fluorophenyl Group Targeting MRSA. Molecules. https://doi.org/10.3390/molecules30112366
Vancouver
Wang Y, Zhao Y, Wang H, Liu B, Zhang S, Liu Y, et al. The Synthesis and Biological Evaluation of a Novel Pleuromutilin Derivative Containing a 4-Fluorophenyl Group Targeting MRSA. Molecules. 2025. doi:10.3390/molecules30112366
BibTeX
@article{Wang2025,
author = {Wang, Yongfei and Zhao, Yi and Wang, Haiting and Liu, Bo and Zhang, Shuangyi and Liu, Yuan and Li, Ruinan and Zhang, Tao and Hasi, Surong and Mao, Wei},
title = {The Synthesis and Biological Evaluation of a Novel Pleuromutilin Derivative Containing a 4-Fluorophenyl Group Targeting MRSA},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30112366}
}
EUVIMED